A rare inherited disorder characterized by abnormal fibrinogen which is a protein essential to the blood clotting process. The Paris II type was discovered in Paris II. See also Paris II dysfibrinogenemia
As scientists who evolve with technology we treat innovation as a way of life, a life we dedicate to improvement and advancement of Safety, Health and Environment.
